1. Home
  2. WGS vs CXW Comparison

WGS vs CXW Comparison

Compare WGS & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
  • CXW
  • Stock Information
  • Founded
  • WGS 2017
  • CXW 1983
  • Country
  • WGS United States
  • CXW United States
  • Employees
  • WGS N/A
  • CXW N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • CXW Real Estate Investment Trusts
  • Sector
  • WGS Technology
  • CXW Real Estate
  • Exchange
  • WGS Nasdaq
  • CXW Nasdaq
  • Market Cap
  • WGS 2.4B
  • CXW 2.4B
  • IPO Year
  • WGS N/A
  • CXW 1997
  • Fundamental
  • Price
  • WGS $121.67
  • CXW $20.56
  • Analyst Decision
  • WGS Strong Buy
  • CXW Strong Buy
  • Analyst Count
  • WGS 7
  • CXW 3
  • Target Price
  • WGS $99.29
  • CXW $33.33
  • AVG Volume (30 Days)
  • WGS 988.8K
  • CXW 1.1M
  • Earning Date
  • WGS 07-29-2025
  • CXW 08-06-2025
  • Dividend Yield
  • WGS N/A
  • CXW N/A
  • EPS Growth
  • WGS N/A
  • CXW 57.89
  • EPS
  • WGS 0.05
  • CXW 0.95
  • Revenue
  • WGS $362,321,000.00
  • CXW $1,997,643,000.00
  • Revenue This Year
  • WGS $22.16
  • CXW $5.37
  • Revenue Next Year
  • WGS $19.63
  • CXW $14.18
  • P/E Ratio
  • WGS $2,540.29
  • CXW $21.78
  • Revenue Growth
  • WGS 48.70
  • CXW 1.62
  • 52 Week Low
  • WGS $28.86
  • CXW $12.13
  • 52 Week High
  • WGS $123.11
  • CXW $24.99
  • Technical
  • Relative Strength Index (RSI)
  • WGS 70.52
  • CXW 50.53
  • Support Level
  • WGS $102.97
  • CXW $19.88
  • Resistance Level
  • WGS $123.22
  • CXW $20.88
  • Average True Range (ATR)
  • WGS 6.99
  • CXW 0.74
  • MACD
  • WGS 1.96
  • CXW 0.12
  • Stochastic Oscillator
  • WGS 87.25
  • CXW 52.94

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

Share on Social Networks: